Evaluation of DEXTENZA in the Management of Pain and Inflammation in Patients With Anterior Uveitis Compared to Standard of Care Topical Corticosteroids

NCT04426734 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Non-infectious Anterior Uveitis

Interventions

DEVICE: Dextenza Dexamethasone Implant
DRUG: Topical Prednisolone Acetate 1%

Sponsor

New England Retina Associates

Collaborators

[object Object]